Clinical Trial

CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis

Name: CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis — clinical trial record (NCT07388277)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety of CC-97540 in relapsed or refractory severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-12

Trial Details

NCT Number	NCT07388277
Lead Sponsor	Marcela V. Maus, M.D.,Ph.D. Collaborators: Bristol-Myers Squibb
Conditions	Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment	12 participants
Start Date	2026-07-09
Primary Completion	2028-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-15